Oppenheimer Upgrades Incyte to Outperform, Raises Price Target to $144

Benzinga · 3d ago
Oppenheimer analyst Jay Olson upgrades Incyte (NASDAQ:INCY) from Perform to Outperform and raises the price target from $120 to $144.